business

Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders - STAT

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.

By:Elaine Chen
Source:STAT
Published:
Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders - STAT
The Food and Drug Administration has declared an end to the shortage of Novo Nordisks blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies. Novos semagluti… [+923 chars]

Related News